PMID: 6540539Jul 1, 1984Paper

Studies of the clinical pharmacology and therapeutic efficacy of pentoxifylline in peripheral obstructive arterial disease

Angiology
T Di PerriG L Messa

Abstract

Studies were carried out to investigate the effects of pentoxifylline on various hemorheological (whole blood, plasma and serum viscosity, erythrocyte filtrability, hematocrit), hemostasiological (blood coagulation and fibrinolysis: euglobulin lysis time, fibrinogen, plasminogen, alpha-2-macroglobulin, alpha-1-antitrypsin, antiplasmin; platelet function: beta-thromboglobulin), and hemodynamic factors (limb perfusion: rest and peak flow, time to peak flow; systemic blood pressure, heart rate). In addition, clinical efficacy was monitored in patients with claudication by assessing walking capacity under placebo controlled double blind cross over conditions. The investigations disclosed the positive influence of acute and chronic pentoxifylline administration on hemorheological, hemostasiological and perfusion parameters, most of the changes recorded being statistically significant. The clinical benefit of pentoxifylline (Trental 400) treatment was demonstrated by the significantly superior increase in walking capacity in comparison to placebo in the controlled study.

Citations

Jul 1, 1997·Thrombosis Research·D A Handley, T E Hughes
Jun 1, 1990·International Journal of Dermatology·M L Frost, P Treadwell
May 1, 1990·Antimicrobial Agents and Chemotherapy·X Sáez-LlorensG H McCracken
Feb 13, 2014·Current Atherosclerosis Reports·Young I ChoRobert S Rosenson
Feb 1, 1992·Cardiovascular Drugs and Therapy·G di Minno, M Mancini
Apr 1, 1994·Journal of the American Academy of Dermatology·C P Samlaska, E A Winfield
Aug 1, 1987·Journal of Clinical Pharmacology·D GillingsW J Stager
Jan 1, 1991·Annals of Vascular Surgery·J KokeshR E Zierler
Apr 1, 1985·Angiology·R Mueller
Dec 1, 1990·Angiology·J C Barnett, R C Touchon

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.